Trademark: 87766080
Status Date
Monday, May 10, 2021
Filing Date
Tuesday, January 23, 2018
Published for Opposition
Tuesday, August 14, 2018
Abandoned Date
Monday, May 10, 2021
5 Pharmaceuticals preparations for the prevention and treatment of central nervous system disorders; Pharmaceuticals preparations for the prevention and treatment of circulatory systems disorders; Pharmaceuticals preparations for the prevention and treatment of sensory organs disorders; Pharmaceuticals preparations for the prevention and treatment of urogenital organs disorders; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of psychological disorders; Contraceptive preparations; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Fertility enhancing preparations; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders
May 10, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
May 10, 2021
Abandonment - No Use Statement Filed
Oct 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Oct 1, 2020
Extension 4 Granted
Oct 1, 2020
Extension 4 Filed
Oct 1, 2020
Teas Extension Received
Apr 8, 2020
Notice Of Approval Of Extension Request E-Mailed
Apr 6, 2020
Extension 3 Granted
Apr 6, 2020
Extension 3 Filed
Apr 6, 2020
Teas Extension Received
Oct 8, 2019
Notice Of Approval Of Extension Request E-Mailed
Oct 4, 2019
Extension 2 Granted
Oct 4, 2019
Extension 2 Filed
Oct 4, 2019
Teas Extension Received
Apr 6, 2019
Notice Of Approval Of Extension Request E-Mailed
Apr 4, 2019
Extension 1 Granted
Apr 4, 2019
Extension 1 Filed
Apr 4, 2019
Teas Extension Received
Oct 9, 2018
Noa E-Mailed - Sou Required From Applicant
Aug 14, 2018
Official Gazette Publication Confirmation E-Mailed
Aug 14, 2018
Published For Opposition
Jul 25, 2018
Notification Of Notice Of Publication E-Mailed
Jul 9, 2018
Assigned To Lie
Jun 23, 2018
Approved For Pub - Principal Register
Jun 8, 2018
Teas/Email Correspondence Entered
Jun 7, 2018
Correspondence Received In Law Office
Jun 7, 2018
Teas Response To Office Action Received
Mar 25, 2018
Notification Of Non-Final Action E-Mailed
Mar 25, 2018
Non-Final Action E-Mailed
Mar 25, 2018
Non-Final Action Written
Mar 24, 2018
Assigned To Examiner
Feb 2, 2018
New Application Office Supplied Data Entered In Tram
Jan 26, 2018
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
